Retatrutide

Retatrutide® is a medication developed by Eli Lilly, administered through a once-weekly injection. its efficacy in treating obesity, managing type 2 diabetes, and potentially addressing other conditions like non-alcoholic fatty liver disease (NAFLD) has been remarkable with patients lately. This triagonist mode of action allows retatrutide to induce the glucose-dependent insulin release from the pancreas via GLP-1 receptors, enhance this GLP-1-mediated effect through GIP receptors, and increase energy expenditure through glucagon receptors. 

Benefits Of Retatrutide: 
.Reduces food intake by lowering appetite. 
.Slows food digestion in the stomach. 
.Helps decrease body fat percentage & weight loss which is superior to Semaglutide. 
.Increases energy expenditure resulting in substantial & sustained reductions in body weight.